How PlexusDx Compounded Semaglutide Maintains Dosing Standards PlexusDx partners with licensed 503A compounding pharmacies that prepare semaglutide injections to pharmaceutical-grade specifications
America is embarking on a risky experiment with GLP-1s and aging Are GLP-1s for life
doi: 10.3390/jcm8091377 47 Lpez-PingarrnLAlmeidaHSoria-AznarMReyes-GonzalesMCTerrnMPGarcaJJ
Novel pharmacological approaches Besides behavioral strategies, emerging pharmacologic agents, comprising anabolic and anti-catabolic drugs, have been demonstrated to be effective in the prevention and treatment of sarcopenia or disproportionate lean mass loss in patients receiving GLP-1RAs
The statements on this page have not been evaluated by the FDA
Glucagon enhances multiple steps in this pathway: Increased lipolysis: Glucagon activates hormone-sensitive lipase in adipose tissue, releasing more fatty acids into circulation Reduced lipogenesis: Glucagon suppresses the enzymes responsible for creating new fat from carbohydrates Enhanced hepatic oxidation: Glucagon upregulates liver enzymes involved in fatty acid oxidation Ketogenesis: When fat oxidation exceeds the citric acid cycle capacity, excess acetyl-CoA is converted to ketone bodies, an alternative fuel source The net effect is a metabolic state favoring fat breakdown over fat storage
